Q2 2024 Nanalysis Scientific Corp Earnings Call Transcript
Key Points
- Nanalysis Scientific Corp (NSCIF) reported a record revenue of $11.5 million for Q2 2024, a 65% increase from the same period in 2023.
- The company achieved a positive EBITDA of $414,000, a significant improvement from the $2.4 million EBITDA loss in Q2 2023.
- Gross margin percentage on product sales improved to 50%, driven by increased sales and reduced manufacturing costs.
- The security service gross margin improved to 10% from a negative 36% in the prior year, following the full transition of airport services to the company's control.
- Nanalysis Scientific Corp (NSCIF) has a strong sales pipeline and expects continued growth in the Benchtop NMR segment, with new product announcements anticipated before the end of the year.
- Despite the positive EBITDA, the company still reported a net loss of $2 million for Q2 2024.
- The medical imaging sales, while contributing to revenue, tend to have lower margins, impacting overall profitability.
- The company’s cash on hand was relatively low at $1.1 million, though it has an undrawn credit facility of $3.2 million.
- There is a noted seasonality in the Benchtop NMR business, with Q3 expected to be softer due to academic market slowdowns.
- The company continues to focus on cost reductions, indicating ongoing challenges in aligning resources and reducing fixed costs.
Good afternoon, ladies and gentlemen, and welcome to the Nanalysis Scientific Q2 2024 conference call. (Operator Instructions) This call is being recorded on Wednesday, August 28, 2024.
I would now like to turn the conference over to Mr. Matthew Selinger, Investor Relations. Please go ahead.
Thank you, operator, and welcome, everyone, to Nanalysis Scientific's second-quarter 2024 conference call. Before we begin, I would like to remind everyone that our remarks and responses to your questions today will contain forward-looking statements that are based on the current expectations of management. These assumptions involve inherent risks and uncertainties that could cause actual results to differ materially from our responses.
Certain material factors and assumptions were considered and applied in the making of the forward-looking statements. These risk factors are included in our filings for the year ended December 31, 2023. Forward-looking statements on this call may
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
